Streetbeat News

Partnerships

CAL

CMTL

FUSN

GWAV

OTRK

SEEL

SPIR

U.S. stocks traded higher with the Nasdaq Composite gaining over 50 points. Caleres Inc reported upbeat Q4 results, beating analyst estimates. Ontrak, Inc. and Fusion Pharmaceuticals Inc. saw significant share price increases, while Greenwave Technology Solutions, Inc., Seelos Therapeutics, Inc., and Comtech Telecommunications Corp. experienced declines. The energy sector rose by 1%, while communication services fell by 0.2%. Oil prices increased, and housing starts in the U.S. surged by 10.7%.

Portfolio Pulse from Avi Kapoor

March 19, 2024 | 7:02 pm

Macy's Inc has agreed to open its books to Arkhouse and Brigade Capital, according to sources cited by Reuters. This move could indicate potential financial scrutiny or investment interest from these entities.

Portfolio Pulse from Happy Mohamed

March 19, 2024 | 6:51 pm

GIL

A spokesperson from Gildan announced that a special committee has conducted targeted outreach to a select few reputable potential counterparties, according to Reuters.

Portfolio Pulse from Happy Mohamed

March 19, 2024 | 6:47 pm

EADSF

EADSY

Boeing Co (NYSE:BA) is currently facing challenges, with discussions on Reddit highlighting its 'too big to fail' status and comparing its situation to historical examples like Citigroup Inc (NYSE:C) and General Motors Co (NYSE:GM). Despite its dominant position alongside Airbus SE (OTCPK: EADSF) (OTCPK: EADSY), Boeing's recovery is uncertain due to production issues and market dynamics.

Portfolio Pulse from Surbhi Jain

March 19, 2024 | 6:40 pm

AAPL

GOOG

IXP

VOX

Google and Apple are reportedly discussing a potential AI partnership involving Google's Gemini AI platform for iOS 18, sparking optimism among analysts. BofA analyst Justin Post reiterated a Buy rating on Alphabet Inc (GOOG, GOOGL) with a $173 price target. The collaboration could enhance iOS with advanced AI features and reinforce Google's AI leadership. However, Apple may still consider other AI providers. The deal's financial terms are undisclosed, but it's expected to involve a technology licensing fee from Apple to Google. Google's stock responded positively to the news, but there's a risk Apple could choose another partner. Investors can also gain exposure to Google through ETFs like VOX and IXP.

Portfolio Pulse from Anusuya Lahiri

March 19, 2024 | 6:39 pm

SOLUSD

The memecoin market on the Solana blockchain has experienced significant volatility, with BOME crashing 50% and other memecoins like Pepe, WIF, Floki, and Bonk dropping around 20%. In contrast, SLERF's value surged, becoming the eighth-largest meme coin by market cap. Cryptocurrency exchanges BingX, HTX, and Bitget have supported SLERF by donating transaction fees. Solana's DEXs outperform competitors, with Raydium's trading volume surpassing Uniswap V3. Solana's fee capture also exceeded Bitcoin's, indicating its growing dominance in DeFi.

Portfolio Pulse from Murtuza Merchant

March 19, 2024 | 6:37 pm

LUNR

Traders are closely monitoring Intuitive Machines amid circulating analyst comments that NASA is expected to issue significant additional CLPS awards, including the imminent IM-4/CP-22 contract, which is anticipated to be awarded to LUNR.

Portfolio Pulse from Happy Mohamed

March 19, 2024 | 6:31 pm

IVDA

Iveda shares are trading higher following the announcement of the expansion of its partnership with Evergreen Aviation Technologies Corp. This development is expected to enhance Iveda's market position and potentially increase its revenue streams through the extended collaboration.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 6:30 pm

AZN

NBIX

NVS

SGMO

VYGR

H.C. Wainwright initiated coverage on Voyager Therapeutics Inc (VYGR) with a Buy rating and a $30 price target, highlighting its potential in gene therapy for CNS disorders. The firm praised Voyager's TRACER capsid discovery platform and its partnerships with Novartis, Neurocrine Biosciences, Sangamo Therapeutics, and Alexion (AstraZeneca). Voyager's financial position is strong, with a cash runway into 2027, bolstered by a collaboration with Novartis on gene therapies for Huntington’s disease and spinal muscular atrophy.

Portfolio Pulse from Vandana Singh

March 19, 2024 | 6:16 pm

AMZN

GOOG

MSFT

NVDA

ORCL

QOWZ

TRFK

TSM

Nvidia's Blackwell GPUs, featuring advanced chip technology and system-level architecture innovations, have sparked analyst excitement, with Wedbush analyst Matt Bryson reiterating an Outperform rating and a $1,000 price target. The new lineup includes the B100, B200, GB200, and GB200 NVL72, promising significant performance gains in AI training and inference. Major cloud providers like Microsoft Azure, Amazon AWS, Alphabet's Google Cloud, and Oracle Cloud have committed to integrating the GB200 NVL72. The launch is seen as a major step in AI innovation, with Nvidia maintaining leadership in the AI accelerator market. Nvidia's stock has seen a significant increase, and exposure to Nvidia's growth in AI can also be gained through ETFs like Invesco Nasdaq Free Cash Flow Achievers ETF and Pacer Funds Pacer Data And Digital Revolution ETF.

Portfolio Pulse from Anusuya Lahiri

March 19, 2024 | 6:11 pm